Food Access
Website Blocks Users Over New Policy
Arabella Whittin · 19/07/2026
Step therapy for Vabysmo leads to treatment delays and higher costs for patients and eye‑care providers, highlighting the financial burden of step‑therapy requi
01
03
Step therapy for Vabysmo leads to treatment delays and higher costs for patients and eye‑care providers, highlighting the financial burden of step‑therapy…
Step therapy for Vabysmo leads to treatment delays and higher costs for patients and eye‑care providers, highlighting the…
Patients with eye disease face worsening conditions after losing access to copay assistance for anti-VEGF drugs, study reveals.
Medicaid reimbursement rates vary widely across states, affecting patient care and vitreoretinal procedures, including vitrectomy and retinal detachment…
FDA approves Merck's Lipfendra to reduce LDL cholesterol in adults with hypercholesterolemia using PCSK9 inhibitor.
The FTC settlement with Caremark and Zinc Health targets pharmacy benefit managers to lower insulin costs and improve…
The U.S. Medicare drug pricing policy may cut costs by matching prices in other wealthy nations, reshaping pharmaceutical…
A new COVID-19 antibody treatment, VYD2311, enters phase 3 trials to evaluate safety and efficacy against mRNA vaccines.
Dermatologists propose ending routine blood tests for isotretinoin patients without risk factors to streamline acne treatment.
New PBM regulations in 2026 enhance transparency. Learn how industry changes impact healthcare practices.
Employers encourage weight loss medications like GLP-1 receptor agonists through direct-to-consumer platforms and health savings accounts for employees.
